Vergleichende Analyse praediktiver Biomarker für therapeutische Strategien beim kolorektalen Karzinom
暂无分享，去创建一个
M. Grimm | A. Thiede | D. Meyer | A. M. Waaga-Gasser | M. Gasser | C. Gerstlauer | E. Nichiporuk | M. Bueter | Uwe Maeder
[1] Shung-Haur Yang,et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? , 2005, The Journal of surgical research.
[2] Norman Wolmark,et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Shung-Haur Yang,et al. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. , 2002, Hepato-gastroenterology.
[4] M. Garcia-Moran,et al. Niveles séricos preoperatorios del CEA y pronóstico en el cáncer colorrectal. , 2001 .
[5] P J Catalano,et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.